NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn ...
If you suffered substantial losses and wish to serve as lead plaintiff of the AstraZeneca class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, both dat ...
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or “the Company”) ...
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of AstraZeneca PLC (NASDAQ ...
More than 50 people have already filed a class action lawsuit against AstraZeneca in the UK, in a case that could result in a multimillion-pound payout. The company asked the EU to withdraw ...
LOS ANGELES, Jan. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ: AZN) for violations of ...
AstraZeneca faces significant challenges amid Chinese investigation and ongoing investor lawsuit regarding alleged misconduct ...
The Portnoy Law Firm advises AstraZeneca PLC ("AstraZeneca PLC" or the "Company") (NASDAQ: AZN) investors of a class action representing investors that bought securities between February 23, 2022 and ...
The total dollar value of class action and mass tort settlements dropped in 2024 but continued to surpass $40 billion for the ...
Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ ...
LOS ANGELES, Dec. 31, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca ...